-
Zydus Cadila launches Enmixamine liquid capsule Obnyx, which will reduce the price of the prostate cancer treatment by 2/3
Time of Update: 2020-05-29
Zydus Cadila has announced the launch of the anti-prostate cancer drug Enzalutamide, known as "Obnyx" in India The introduction of Obnyx can significantly reduce the cost of treatment by nearly 70
-
Live Previews China and the West together together to move forward"oncology comprehensive treatment innovation road summit forum invited you to participate!
Time of Update: 2020-05-29
At present, the spread of new coronary pneumonia in the world, slow disease diagnosis and treatment is facing the double pressure of patient treatment and prevention of infection, how to standardiz
-
Burning Stone Medicine Goes to U.S. IPO, Plus Code Research and Development Grabs Hundreds of Billions of Cancer Early Detection New Track
Time of Update: 2020-05-29
Rushing away 205 billion cancer early detection Blue Sea, half of enterprises valued or derived from the early inspection since its establishment, Burning Stone Medicine has completed a total o
-
The field of hepatobiliary is the most desirable three target new drug introduction, so that liver cancer patients have more choices!
Time of Update: 2020-05-29
Recently approved the market of FGFR2 target drug pemigatinib, Peugeot liver and bile tumors into the new world of precision target treatment, what is the future to look forward to the new directio
-
Blood: The efficacy of Daremu mono-anti-to-take-to-natamine-borazonandand and dexamethasone to treat newly diagnosed transplantable multiple myeloma
Time of Update: 2020-05-29
Self-stem cell transplantation (ASCT) after treatment with Nalaamine, boronitami and Dexameton (RVd) is the standard first-line therapy for newly diagnosed patients with multiple myeloma (NDMM) for
-
Radiology: Reduced hand movement restfunction function connection in glioma patients
Time of Update: 2020-05-29
Background the clinical application of resting function MRI has great potential, but it is limited by the current understanding of the results of tumor resting function MRI purposes this stud
-
Nat Neuro: New immunotherapy combination may be effective in treating pediatric brain cancer
Time of Update: 2020-05-29
Introduction: Oncologists know that "chemotherapy and radiotherapy" is one of the preferred anti-cancer therapies Because the combination of chemotherapy can kill cancer cells more effectively Howe
-
Cell Death Dis: LncRNA KCNQ1OT1 Promotes Osteosarcoma Progress by Enhancing Aerobic Sugar Enzymes
Time of Update: 2020-05-29
Ostoma (OS) is one of the most invasive and common primary malignant bone tumors, most common in children and adolescents With the progress of various treatments, such as surgery, chemotherapy and
-
Only 0.8% of heart tumors are primary malignancies, 5 years survival rate of less than 12%! JACC U.S. Cancer Data
Time of Update: 2020-05-29
Recently, national cancer data from the JACC showed that only 0.8% of all heart tumors are primary malignancies 88.5% of these primary malignancies were sarcoma, the majority of which were hema
-
Nature Sub-journal: Triple therapy for fasting and vitamin C-plus chemotherapy is effective for hard-to-treat cancers
Time of Update: 2020-05-29
A study published May 11 in Nature Communications shows that the combination of fasting and vitamin C has an effect on the of untreatable cancers scientists at the University of Southern Califo
-
CELL: Metabolically driven epithelial group leads to fatal infant ventricular membrane tumors
Time of Update: 2020-05-29
Post-cranial (PFA) ventricular membrane tumor is a fatal malignant tumor in the infant's back brain PFA infant ventricular membrane tumors are considered epigenetic-driven tumors due to the lack of
-
NMPA: Approved Reding Pharmaceutical Oncology Electric Field Therapy for The Market for Glioblastoma Treatment, Ushering in a New Era of Treatment
Time of Update: 2020-05-29
Today from The Company learned from Reding Pharmaceuticals, the company from Israel, called Optune tumor electric field therapy (TTFields) products to obtain the National Drug Administration (NMPA)
-
Cancer: New research: Eating too much chili really increases the risk of stomach cancer!
Time of Update: 2020-05-29
For people with bad stomachs, doctors often recommend eating less "cold and spicy"; but previous studies have shown that chili peppers do not have any destructive effect on the gastric mucosa, bu
-
NAT MED: Antioxidant Key Protein Spromotes Relapse of Dormant Tumor Cells?
Time of Update: 2020-05-29
Dormant tumor cells survive and relapse after treatment are the leading causes of death in cancer patients Previous studies have shown that the metabolic properties of these cells may differ from t
-
Cell Death Dis: Tumor-related fibroblasts can affect the circadian rhythms of colon cancer cells
Time of Update: 2020-05-29
The biological clock regulates the expression level of proteins and their functional characteristics, such as the rhythms associated with cell growth, which regulate the overall activity of cells i
-
Pomadoamine is FDA approved as the first treatment for AIDS-related Caposi sarcoma in more than 20 years
Time of Update: 2020-05-29
Bristol Myers Squibb has announced that its Pomalyste (pomalidomide, Pomadomide) has been approved by the U.S Food and Drug Administration (FDA) to treat patients with Kaposi sarcoma who develop re
-
Professor Xu Jianmin Explains Treatment for Hepatometymety Patients With Non-Recital Colorectal Cancer (BECOME Study)
Time of Update: 2020-05-29
In 2013, Professor Xu Jianmin's team published the results of treatment for RAS wild-type CRC liver metastasis patients with citoxil monoantigen combined with mFOLFOX6 in Journal of Clinical Oncolo
-
Nat Commun: Study confirms that triple therapy for fasting and vitamin C-plus chemotherapy is effective for hard-to-treat cancers
Time of Update: 2020-05-29
Introduction: According to different preclinical and clinical trials, the pharmacological dose of vitamin C (ascorbic acid) has been proposed as a potential anti-cancer drug Recent studies have sho
-
Jiangxi's first multidisciplinary standardized treatment center for stage III lung cancer was established
Time of Update: 2020-05-29
On May 13, 2020, the China Lung Cancer Rare Mutation Collaboration Group was launched online, marking the official establishment of China's first collaboration group for rare mutations in lung canc
-
Brit J Cancer: Male breast cancer patients benefit from survival with tamoxifen treatment
Time of Update: 2020-05-29
Due to the lack of forward-looking data, current treatment for male breast cancer (MBC) is based primarily on retrospective analysis or information from female patient studies In a recent study pub
